Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("VON BAHR C")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 132

  • Page / 6
Export

Selection :

  • and

BINDING AND OXIDATION OF AMITRIPTYLINE AND A SERIES OF ITS OXIDIZED METABOLITES IN LIVER MICROSOMES FROM INTREATED AND PHENOBARBITAL-TREATED RATS = FIXATION ET OXYDATION DE L'AMITRIPTYLINE ET DE SERIES DE SES METABOLITES OXYDES DANS LES MICROSOMES DE FOIE DE RATS TRAITES OU NON PAR LE PHENOBARBITALVON BAHR C.1972; XENOBIOTICA; G.B.; DA. 1972; VOL. 2; NO 3; PP. 293-306; BIBL. 1 P.Serial Issue

DEMETHYLATION AND HYDROXYLATION OF AMITRIPTYLINE, NORTRIPTYLINE, AND 10-HYDROXYAMITRIPTYLINE IN HUMAN LIVER MICROSOMESMELLSTROEM B; VON BAHR C.1981; DRUG METAB. DISPOS.; ISSN 0090-9556; USA; DA. 1981; VOL. 9; NO 6; PP. 565-568; BIBL. 25 REF.Article

DETERMINATION OF (R)- AND (S)-ALPRENOLOL AND (R)- AND (S)-METOPROLOL AS THEIR DIASTEREOMERIC DERIVATIVES IN HUMAN PLASMA BY REVERSED-PHASE LIQUID CHROMATOGRAPHYHERMANSSON J; VON BAHR C.1982; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1982; VOL. 227; NO 1; PP. 113-127; BIBL. 15 REF.Article

SIMULTANEOUS DETERMINATION OF D AND L-PROPRANOLOL IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHYHERMANSSON J; VON BAHR C.1980; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1980; VOL. 221; NO 1; PP. 109-117; BIBL. 21 REF.Article

ALPHA -RECEPTOR FUNCTION CHANGES AFTER THE FIRST DOSE OF PRAZOSINVON BAHR C; LINDSTROEM B; SEIDEMAN P et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 1; PP. 41-47; BIBL. 34 REF.Article

METABOLISM OF A GLUTATHIONE CONJUGATE IN HUMAN FETAL AND ADULT TISSUESMOLDEUS P; VON BAHR C; RANE A et al.1980; DEV. PHARMACOL. THER.; CHE; DA. 1980; VOL. 1; NO 1; PP. 83-89; BIBL. 15 REF.Article

PLASMA LEVELS AND EFFECTS OF METOPROLOL AFTER SINGLE AND MULTIPLE ORAL DOSESCOLLSTE P; HAGLUND K; VON BAHR C et al.1980; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1980; VOL. 27; NO 4; PP. 441-449; BIBL. 40 REF.Article

OXIDATION OF (R)- AND (S)-PROPRANOLOL IN HUMAN AND DOG LIVER MICROSOMES. SPECIES DIFFERENCES IN STEREOSELECTIVITYVON BAHR C; HERMANSSON J; LIND M et al.1982; JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS; ISSN 0022-3565; USA; DA. 1982; VOL. 222; NO 2; PP. 458-462; BIBL. 42 REF.Article

PLASMA LEVELS OF (+) AND (-) PROPRANOLOL AND 4-HYDROXYPROPRANOLOL AFTER ADMINISTRATION OF RACEMIC ( +OU- ) PROPRANOLOL IN MANVON BAHR C; HERMANSSON J; TAWARA K et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 14; NO 1; PP. 79-82; BIBL. 18 REF.Article

SULPHATE AND GLUCURONIC ACID CONJUGATION OF HARMOL IN HUMAN FETAL AND ADULT LIVER TISSUESTEINER E; VON BAHR C; RANE A et al.1982; DEV. PHARMACOL. THER.; ISSN 0379-8305; CHE; DA. 1982; VOL. 5; NO 1-2; PP. 14-20; BIBL. 2 P.Article

MECHANISM OF N-HYDROXYACETYLARYLAMINE MUTAGENICITY IN THE SALMONELLA TEST SYSTEM: METABOLIC ACTIVATION OF N-HYDROXYPHENACETIN BY LIVER AND KIDNEY FRACTIONS FROM RAT, MOUSE, HAMSTER, AND MANWIRTH PJ; DYBING E; VON BAHR C et al.1980; MOLEC. PHARMACOL.; USA; DA. 1980; VOL. 18; NO 1; PP. 117-127; BIBL. 30 REF.Article

INTERINDIVIDUAL VARIATION IN BENZO(A) PYRENE METABOLISM AND COMPOSITION OF ISOENZYMES OF CYTOCHROME P-450 AS REVEALED BY SDS-GEL ELECTROPHORESIS OF HUMAN LIVER MICROSOMAL FRACTIONSEKSTROM G; VON BAHR C; GLAUMANN H et al.1982; ACTA PHARMACOL. TOXICOL.; ISSN 0001-6683; DNK; DA. 1982; VOL. 50; NO 4; PP. 251-260; BIBL. 24 REF.Article

METABOLISM OF LIDOCAINE IN HUMAN LIVER IN VITROHERMANSSON J; GLAUMANN H; KARLEN B et al.1980; ACTA PHARMACOL. TOXICOL.; DNK; DA. 1980; VOL. 47; NO 1; PP. 49-52; BIBL. 6 REF.Article

Distribution of remoxipride to the human brain and central D2- dopamine receptor binding examined in vivo by PETFARDE, L; VON BAHR, C.Acta psychiatrica scandinavica. Supplementum. 1990, Vol 82, Num 358, pp 67-71, issn 0065-1591, 6 p.Conference Paper

CONTRIBUTION OF 4-HYDROXY-ALPRENOLOL TO ADRENERGIC BETA RECEPTOR BLOCKADE OF ALPRENOLOLCOLLSTE P; BORG KO; ASTROM H et al.1979; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1979; VOL. 25; NO 4; PP. 415-422; BIBL. 18 REF.Article

BIOAVAILABILITY AND PHARMACOKINETICS OF CIMETIDINEGRAHNEN A; VON BAHR C; LINDSTROM B et al.1979; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1979; VOL. 16; NO 5; PP. 335-340; BIBL. 22 REF.Article

KINETICS OF NORTRIPTYLINE (NT) IN RATS IN VIVO AND IN THE ISOLATED PERFUSED LIVER: DEMONSTRATION OF A FIRST PASS DISAPPEARANCE OF NT IN THE LIVER = CINETIQUE DE LA NORTRIPTILYNE(NT) CHEZ LES RATS IN VIVO ET DANS LE FOIE PERFUSE ISOLE: DEMONSTRATION DE LA DISPARITION DANS LE PREMIER PASSAGE DE LA NT DANS LE FOIEVON BAHR C; BORGA O; FELLENIUS E et al.1973; PHARMACOLOGY; SWITZ.; DA. 1973; VOL. 9; NO 3; PP. 177-186; BIBL. 2P.Serial Issue

EFFECT OF PENTOBARBITAL ON THE DISPOSITION OF ALPRENOLOL.ALVAN G; PIAFSKY K; LIND M et al.1977; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1977; VOL. 22; NO 3; PP. 316-321; BIBL. 18 REF.Article

IN VITRO BIOTRANSFORMATION OF GLUCOCORTICOIDS IN LIVER AND SKIN HOMOGENATE FRACTION FROM MAN, RAT AND HAIRLESS MOUSEANDERSSON P; EDSBAECKER S; RYRFELDT A et al.1982; J. STEROID BIOCHEM.; ISSN 0022-4731; GBR; DA. 1982; VOL. 16; NO 6; PP. 787-795; BIBL. 20 REF.Article

EFFECT OF PENTOBARBITAL ON THE FORMATION OF DIASTEREOMERIC OXAZEPAM GLUCURONIDES IN MAN: ANALYSIS BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHYSEIDEMAN P; ERICSSON O; GRONINGSSON K et al.1981; ACTA PHARMACOL. TOXICOL.; ISSN 0001-6683; DNK; DA. 1981; VOL. 49; NO 3; PP. 200-204; BIBL. 18 REF.Article

PURIFICATION OF A NEW GLUTATHIONE S-TRANSFERASE (TRANSFERASE MU ) FROM HUMAN LIVER HAVING HIGH ACTIVITY WITH BENZO (ALPHA ) PYRENE-4,5-OXIDEWARHOLM M; GUTHENBERG C; MANNERVIK B et al.1981; BIOCHEM. BIOPHYS. RES. COMMUN.; ISSN 0006-291X; USA; DA. 1981; VOL. 98; NO 2; PP. 512-519; BIBL. 22 REF.Article

INHIBITION OF HEPATIC METABOLISM OF AZATHIOPRINE BY FUROSEMIDE IN HUMAN LIVER IN VITROVON BAHR C; GLAUMANN H; GUDAS J et al.1980; BIOCHEM. PHARMACOL.; GBR; DA. 1980; VOL. 29; NO 10; PP. 1439-1441; BIBL. 10 REF.Article

IMPORTANCE OF "FIRST-PASS ELIMINATION" FOR INTERINDIVIDUAL DIFFERENCES IN STEADY-STATE CONCENTRATIONS OF THE ADRENERGIC BETA -RECEPTOR ANTAGONIST ALPRENOLOL.ALVAN G; LIND M; MELLSTROM B et al.1977; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1977; VOL. 5; NO 3; PP. 193-205; BIBL. 26 REF.Article

STOICHIOMETRIC INTERACTION OF A BETA -RECEPTOR BLOCKING DRUG WITH FRACTION OF LIVER CYTOCHROME P-450 AS A POSSIBLE CAUSE FOR ITS DOSE DEPENDENT AVAILABILITY = INTERACTION STOECHIOMETRIQUE D'UN MEDICAMENT BETA -BLOQUANT AVEC LA FRACTION DU CYTOCHROME P-450 DU FOIE COMME CAUSE POSSIBLE DE SON UTILISATION DEPENDANT DE LACTOSEVON BAHR C; VADI H; NORLIN A et al.1976; ACTION PHARMACOL. TOXICOL.; DANEM.; DA. 1976; VOL. 38; NO 5; PP. 513-524; BIBL. 2 P. 1/2Article

Human liver microsomal cytochrome P-450IIE1. Immunological evaluation of its contribution to microsomal ethanol oxidation, carbon tetrachloride reduction and NADPH oxidase activityEKSTROM, G; VON BAHR, C; INGELMAN-SUNDBERG, M et al.Biochemical pharmacology. 1989, Vol 38, Num 4, pp 689-693, issn 0006-2952Article

  • Page / 6